Cowen says buy Regeneron, success of drugs could help pharmaceutical stock

Regeneron’s stock could get a boost as one major drug gains a competitive edge and another continues to dominate, according to Cowen. Analyst Tyler Van Buren on Monday upgraded pharmaceutical stocks to outperform the market. He also raised his price…








